Alexandre Perera Lluna
Jefe de Grupo Senior
Research group
Last Publications
- Ezquerra-Condeminas P, Martinez-Perez A, Howald C, Brown AA, Souto JC, Viñuela A, Buil A, Perera A and Soria JM Gene expression integration and similarity score-based modeling improve risk stratification in idiopathic venous thrombophilia. JOURNAL OF THROMBOSIS AND HAEMOSTASIS . 24(8): 3002-3016.
- Nafria-Escalera B, Perera A, Gaillard S, Dehlinger-Kremer M, Dicks P, Fernandes RM, Vassal G, Lepola P, Egger GF, Bray L, Bierer BE and Phillips B Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007-2024) Reported in the ClinicalTrials.gov Database Pharmaceutical Medicine . 40(4): 311-324.
- Palmieri F, Castellano-Escuder P, Parra-Vargas MC, Leal-Witt MJ, Ramon-Krauel M, Lerin C, Perera A and Jimenez-Chillaron JC Predictive epigenetic biomarkers of successful weight-loss intervention in pre-pubertal children with obesity Clinical Epigenetics . 18(1): .
Projects
- Project name:
- Design, Implementation and Development of a Psychosocial Study on COVID-19 Vaccine Trial Participation (RBDCOV Project)
- Leader
- Begoña Nafria Escalera
- Funding entities:
- European AIDS Treatment Group
- Code
- PFE00112
- Starting - finishing date:
- 2023 - 2024
News
-
Retaining talent and fostering public-private partnerships, some of the challenges that is facing the HealthTech sector
Xartec Salut has opened the debate on the main challenges of the Catalan ecosystem to become an international reference in the field of health technologies.
